CNMD Dividend: Conmed Corp Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

CNMD Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,347	1,307	1,244	1,045	1,010	862
Revenue Growth (YoY)	5%	5%	19%	3%	17%	-10%
Cost of Revenue	617	573	568	474	442	394
Gross Profit	730	733	676	571	568	468
Selling, General & Admin	523	371	296	420	381	332
Research & Development	54	54	52	47	43	40
Operating Expenses	611	523	554	501	457	406
Other Non Operating Income (Expenses)	0	0	0	-8	--	0
Pretax Income	85	163	80	-70	73	1
Income Tax Expense	21	30	16	9	10	-7
Net Income	64	132	64	-80	62	9
Net Income Growth	-51%	106%	-180%	-229%	589%	-68%
Shares Outstanding (Diluted)	31.05	31.15	31.54	30	32.2	29.5
Shares Change (YoY)	0%	-1%	5%	-7%	9%	0%
EPS (Diluted)	2.05	4.25	2.04	-2.68	1.94	0.32
EPS Growth	-52%	108%	-176%	-238%	505.99%	-67%
Free Cash Flow	148	153	106	11	96	51
Free Cash Flow Per Share	4.76	4.91	3.35	0.36	2.98	1.72
Gross Margin	54.19%	56.08%	54.34%	54.64%	56.23%	54.29%
Operating Margin	8.68%	15.99%	9.72%	6.69%	10.89%	7.07%
Profit Margin	4.75%	10.09%	5.14%	-7.65%	6.13%	1.04%
Free Cash Flow Margin	10.98%	11.7%	8.52%	1.05%	9.5%	5.91%
EBITDA	151	243	156	103	143	95
EBITDA Margin	11.21%	18.59%	12.54%	9.85%	14.15%	11.02%
D&A For EBITDA	34	34	35	33	33	34
EBIT	117	209	121	70	110	61
EBIT Margin	8.68%	15.99%	9.72%	6.69%	10.89%	7.07%
Effective Tax Rate	24.7%	18.4%	20%	-12.85%	13.69%	-700%